Symbol="LUMO"
AssetType="Common Stock"
Name="Lumos Pharma Inc"
Description="Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. The company is headquartered in Austin, Texas."
CIK="1126234"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2503 SOUTH LOOP DRIVE, SUITE 5100, AMES, IA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="23122600"
EBITDA="-32298000"
PERatio="None"
PEGRatio="None"
BookValue="7.21"
DividendPerShare="0"
DividendYield="0"
EPS="-3.76"
RevenuePerShareTTM="0.182"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.258"
ReturnOnEquityTTM="-0.457"
RevenueTTM="2103000"
GrossProfitTTM="1523000"
DilutedEPSTTM="-3.76"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.22"
AnalystTargetPrice="17.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="22.45"
PriceToBookRatio="0.405"
EVToRevenue="1.11"
EVToEBITDA="1.564"
Beta="0.566"
num_52WeekHigh="9.56"
num_52WeekLow="2.72"
num_50DayMovingAverage="3.421"
num_200DayMovingAverage="3.89"
SharesOutstanding="8170500"
DividendDate="2020-03-19"
ExDividendDate="None"
symbol="LUMO"
open="2.93"
high="2.95"
low="2.72"
price="2.83"
volume="32963.00"
latest_trading_day="2023-08-16"
previous_close="2.95"
change="-0.12"
change_percent="-4.0678%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="52"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="20089"
Change_recent_avg="-0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.56"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="1138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0171.jpeg"
image_negative_thumbnail_id_2="144"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="639"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0069.jpeg"
image_positive_thumbnail_id_2="982"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
